Overview

Evaluation of the Use of Indomethacin as Co-treatment in Women With Preterm Labor and High Risk of Intraamniotic Inflammation

Status:
Completed

Trial end date:
2014-09-01

Target enrollment:

Participant gender:

Summary

To demonstrate if indomethacin associated to conventional treatment for preterm labor is useful to delay delivery and to improve neonatal morbimortality in women with preterm labor with high risk of intraamniotic inflammation

Phase:

Phase 2

Details

Lead Sponsor:

Sara Varea

Treatments:

Indomethacin